Plumbline Life Sciences, Inc.

A222670

KR7222670002

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
6,180 ^KRW	+0.32%		+0.32%	+2.32%

2023	Plumbline Life Sciences, Inc. announced that it has received KRW 500.12 million in funding	CI
2023	Plumbline Life Sciences, Inc. announced that it expects to receive KRW 500.12 million in funding	CI

Plumbline Life Sciences, Inc. announced that it has received KRW 1 billion in funding

March 22, 2019

On March 22, 2019, Plumbline Life Sciences, Inc. (XKON:A222670) closed the transaction.

Latest news about Plumbline Life Sciences, Inc.

Plumbline Life Sciences, Inc. announced that it has received KRW 500.12 million in funding	24/23/24	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 500.12 million in funding	23/23/23	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 500.12 million in funding	23/23/23	CI
Plumbline Life Sciences, Inc. announced that it has received KRW 599.994 million in funding	14/23/14	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 599.994 million in funding	03/23/03	CI
Plumbline Life Sciences, Inc. announced that it has received KRW 50 million in funding	07/23/07	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 50 million in funding	06/23/06	CI
Plumbline Life Sciences, Inc. announced that it has received KRW 100 million in funding	07/22/07	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 100 million in funding	06/22/06	CI
Plumbline Life Sciences, Inc. announced that it has received KRW 110 million in funding	10/22/10	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 110 million in funding	27/22/27	CI
Plumbline Life Sciences, Inc. announced that it has received KRW 740 million in funding	04/22/04	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 740 million in funding	27/21/27	CI
Plumbline Life Sciences, Inc. announced that it has received KRW 1.2606 billion in funding	27/21/27	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 1.2606 billion in funding	19/21/19	CI
Plumbline Life Sciences, Inc. announced that it has received KRW 1.1 billion in funding from DADAM Investment Corp.	04/20/04	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 1.1 billion in funding from DADAM Investment Corp.	23/20/23	CI
Plumbline Life Sciences, Inc. announced that it has received KRW 45 billion in funding	16/19/16	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 45 billion in funding	08/19/08	CI
Inovio Pharmaceuticals Inc. and Plumbline Life Sciences Establish Animal Health Collaboration to Develop a Novel Vaccine Against Deadly African Swine Fever Virus	15/19/15	CI
Plumbline Life Sciences, Inc. announced that it has received KRW 1 billion in funding	22/19/22	CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 1 billion in funding	14/19/14	CI
Apiam Animal Health Limited Enters into a Distribution Agreement with Plumbline Life Sciences	18/18/18	CI
Plumbline Life Sciences, Inc. announced that it has received KRW 635 million in funding	13/17/13	CI
Plumbline Life Sciences, USA, Inc. announced that it has received funding from Plumbline Life Sciences, Inc.	03/16/03	CI

Chart Plumbline Life Sciences, Inc.

Duration

Period

More charts

Plumbline Life Sciences, Inc. is a Korea-based company mainly engaged in the research and development, manufacture and distribution of bio pharmaceuticals for animals using gene therapy. The Company provides small animal personalized medicines, infectious vaccines, growth hormone releasing hormone (GHRH), telomerase reverse transcriptase (TERT) and others. The Companyâs products are mainly used for pigs, cats, dogs, cows, horses and other animals.

Sector

Pharmaceuticals

Calendar

03/06/2024 - Investor Meeting

More about the company

Sector Biopharmaceuticals

	1st Jan change	Capi.
PLUMBLINE LIFE SCIENCES, INC.	+2.32%	12.61M
CSL LIMITED	-2.29%	89.87B
SAMSUNG BIOLOGICS CO.,LTD.	-3.95%	37.57B
BIOGEN INC.	-13.07%	32.75B
UCB	+63.05%	26.47B
BIOMARIN PHARMACEUTICAL INC.	-22.14%	14.25B
INCYTE CORPORATION	-7.96%	12.99B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.33%	11.93B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-46.33%	10.84B
SWEDISH ORPHAN BIOVITRUM AB	+5.77%	9.11B

Biopharmaceuticals